通过IGF2BP2介导的m6A修改SLC7A11以调节非小细胞肺癌细胞中的增殖和铁化
Bo Li1, Si-Ying Li2, Yi-Chao Yan3
1Department of Thoracic Surgery, Yingkou Central Hospital, China.
概括
胰岛素样生长因子2mRNA结合蛋白2 (IGF2BP2) 通过m6A修饰稳定非小细胞肺癌 (NSCLC) 中的SLC7A11mRNA. 这一过程促进了瘤细胞的增殖,并抑制了铁亡,这表明了新的治疗点.
科学领域:
- 分子瘤学分子瘤学
- 癌症生物学 癌症生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 胰岛素样生长因子2 mRNA结合蛋白2 (IGF2BP2) 与各种癌症有关.
- IGF2BP2在铁和非小细胞肺癌 (NSCLC) 细胞行为中的确切作用尚不清楚.
- 了解IGF2BP2的功能对于开发有针对性的NSCLC疗法至关重要.
研究的目的:
- 调查IGF2BP2介导的N6-甲基氨酸 (m6A) 修饰对溶解物载体家族7成员11 (SLC7A11) 的影响.
- 确定这种修饰如何影响铁和NSCLC细胞活力.
- 阐明IGF2BP2在NSCLC进展中的作用背后的分子机制.
主要方法:
- 使用的NSCLC H1299细胞与IGF2BP2和SLC7A11等离子体/siRNA转染.
- 量化基因和蛋白质表达,使用RT-qPCR和西布洛特.
- 通过CCK-8测定,流细胞计,生物化学工具包和RIP测定评估细胞活力,活性氧物种 (ROS),脂质过氧化和mRNA稳定性.
主要成果:
- 在H1299细胞中IGF2BP2过度表达增加了细胞活力并减少了铁亡.
- 通过m6A修改,IGF2BP2增强了SLC7A11mRNA的稳定性,扭转了IGF2BP2淘汰的影响.
- 这种IGF2BP2-SLC7A11相互作用导致细胞活力增加,ROS和脂质过氧化减少.
结论:
- IGF2BP2通过m6A修饰稳定SLC7A11mRNA,促进NSCLC细胞增殖并抑制铁亡.
- IGF2BP2-SLC7A11轴是NSCLC中瘤细胞行为的关键调节器.
- 向IGF2BP2-SLC7A11通路为NSCLC治疗提供了一个潜在的治疗策略.
相关概念视频
02:23Abnormal Proliferation
4.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.3K
01:22PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
03:03mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
02:04Covalently Linked Protein Regulators
6.6K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.6K
01:26Protein Modifications in the RER
4.8K
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal...
4.8K